HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Chemical Medicine	1.95B	2.25B	2.52B	2.97B	2.98B
Traditional Chinese Medicine	180.56M	182.09M	100.96M	134.54M	148.43M
Others	4.38M	5.02M	7.80M	6.73M	19.45M
Total	2.14B	2.44B	2.63B	3.11B	3.15B

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	2.13B	2.44B	2.62B	3.10B	3.14B
Overseas	5.31M	3.75M	2.36M	6.11M	4.88M
Total	2.14B	2.44B	2.63B	3.11B	3.15B

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error